/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | UTMDUTAH MEDICAL PRODUCT |
|---|---|
| Last close | $67.96 |
| Change % | -0.61% |
| Market cap | $216M |
| P/E | 20.1 |
| Revenue | $38M |
| Rev growth (YoY) | -4.4% |
| Net income | $11M |
| Net margin | 28.9% |
| EPS (diluted) | $3.38 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 42.68 |
| Beneish M-Score | — |
| Next earnings | 07-18 → 07-28 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.